previously clinical reports of CagriSema identified that it helped sufferers obtain appreciably bigger weight loss than semaglutide (Wegovy) did. regardless of whether Lilly's Zepbound/Mounjaro topples Wegovy, It is really doable that CagriSema could enter the marketplace at the appropriate time for Novo Nordisk to keep its All round leadership wit